Apeloa Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 000739.SZ

Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2023: USD 32.33 M

Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities is USD 32.33 M for the year ending December 31, 2023, a -52.62% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2022 was USD 68.23 M, a 33.82% change year over year.
Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2021 was USD 50.98 M, a 60.27% change year over year.
Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2020 was USD 31.81 M, a 14.76% change year over year.
Apeloa Pharmaceutical Co.,Ltd Total Non-Current Liabilities for the year ending December 31, 2019 was USD 27.72 M, a -5.98% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Shenzhen Stock Exchange: 000739.SZ

Apeloa Pharmaceutical Co.,Ltd

CEO	Mr. Fangmeng Zhu
IPO Date	May 9, 1997
Location	China
Headquarters	No. 333, Jiangnan Road
Employees	7,208
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Personal Care Pet Food Vaccines

Description

Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. It also provides contract research and development, and production services for pharmaceutical companies. The company is headquartered in Dongyang, China.

Key trends

Past 5 years